Enhancing lobaplatin sensitivity in lung adenocarcinoma through inhibiting LDHA-targeted metabolic pathways. Yuan S, Ou W, Mi X, Hou J, et al. PLoS One 2024;19:e0310825.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yuan S, Ou W, Mi X, Hou J, et al. Enhancing lobaplatin sensitivity in lung adenocarcinoma through inhibiting LDHA-targeted metabolic pathways. PLoS One 2024;19:e0310825.
PMID: 39680520